TD Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
VPM
TD Asset Management's AMPH Position: Q2 2026 in Review
TD Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 1,541,044 shares — an estimated $30.2M sold.
TD Asset Management first reported a position in AMPH in Q2 2022 and held it in 14 quarters. The position peaked at $103M in Q3 2024. 159 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- TD Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- TD Asset Management sold 1,541,044 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $30.2M.
- TD Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 14 quarters.
- TD Asset Management's Amphastar Pharmaceuticals position peaked at $103M in Q3 2024.
- 159 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.